Delivery Order SPE2DB24D3015-SPE2DB26FFWRW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,217.54 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a $2,207.23 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 2, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $5,863.25 and a completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,516.15 on October 15, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed price contract with an ultimate completion date of October 16, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets (100 count) with a ceiling value of $2,377.11. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for ultimate completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,325.28 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100 count) on October 15, 2025, with completion scheduled for October 16, 2025. This non-competitive, firm fixed-price delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Glimepiride 4 mg tablets (100-count units) at a ceiling value of $2,785.80. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by May 14, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,968.93 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100, with a contract value of $9,136.01 and a completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWRWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,375.62 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. The contract utilizes firm fixed price pricing and was competitively awarded without a set-aside designation. The order was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, leverages this prime IDC to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The company's extensive federal contract portfolio with DLA demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/16/25 |